The puzzle of how a drug that binds to a protein found in normal cells as well as cancer cells preferentially kills tumours is now solved — the target protein exists in a drug-binding complex in tumour cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ferrarini, M., Heltai, S., Zocchi, M. R. & Rugarli, C. Int. J. Cancer 51, 613–619 (1992).
Kamal, A. et al. Nature 425, 407–410 (2003).
Ritossa, F. Cell Stress Chaperones 1, 97–98 (1996).
Maloney, A. & Workman, P. Expert Opin. Biol. Ther. 2, 3–24 (2002).
Chiosis, G. et al. Chem. Biol. 8, 289–299 (2001).
Scheibel, T. & Buchner, J. Biochem. Pharmacol. 56, 675–682 (1998).
Banerji, U. et al. Proc. 93rd Ann. Meet. Am. Assoc. Cancer Res. 43, A1352 (2002).
Jez, J. M., Chen, J., Rastelli, G., Stroud, R. M. & Santi, D. V. Chem. Biol. 10, 361–368 (2003).
Rinehart, K. L. & Shields, L. S. Fortschr. Chem. Org. Naturstoffe 33, 231–307 (1976).
Panaretou, B. et al. Mol. Cell 10, 1307–1318 (2002).
Riggs, D. L. et al. EMBO J. 22, 1158–1167 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neckers, L., Lee, YS. The rules of attraction. Nature 425, 357–359 (2003). https://doi.org/10.1038/425357a
Issue Date:
DOI: https://doi.org/10.1038/425357a